Font Size: a A A
Keyword [androgen deprivation]
Result: 21 - 40 | Page: 2 of 3
21. Analysis Of Related Factors Influencing PSA Kinetics After Androgen Deprivation Therapy In Metastatic Prostate Cancer
22. Different Levels Of Serum PSA Levels In Patients With Prostate Cancer Comparison Of Data On Total Androgen Blockade Therapy
23. The Application Of Quantitative Dynamic Contrast-Enhanced MRI In Differential Diagnosis Of Prostate Cancer Of Different Anatomical Regions And Assessing The Effects Of Androgen Deprivation Therapy For Prostate Cancer
24. Different Androgen Deprivation Therapy For Advanced Prostate Cancer Study On The Relationship Between The Risk Of Secondary Diabetes And Impaired Glucose Tolerance
25. Analysis Of Short Term Castration Resistance In Patients With Advanced Metastatic Prostate Cancer
26. Analysis Of The Improvement Of LUTS Symptoms In Prostate Cancer Patients After Androgen-deprivation Therapy
27. Homing Profiles Of Mesenchymal Stem Cells In Mouse Models And Metastasis And Therapy Efficiency In Prostate Cancer Models
28. Role Of Notch Signaling In Resistance To Androgen Deprivation Therapy In Prostate Cancer
29. Metformin Enhances The Anti-cancer Effect Of Androgen Deprivation Therapy By Inhibiting Tumor Associated Macrophage And EMT
30. MRI-based Texture Analysis Of The Primary Tumor For The Prediction Of Bone Metastases,therapeutic Evaluation Of Androgen Deprivation Therapy In Prostate Cancer
31. Exercise Overcome Adverse Effects Among Prostate Cancer Patients Receiving Androgen Deprivation Therapy An Update Meta-analysis
32. The Mechanism Of Lipid Metabolism In PCa Cells
33. A Retrospective Analysis Of The Application Of Bisphosphonate In Skeletal-related Events Of Prostate Cancer After ADT
34. Clinical Factors About Patients With Prostate Cancer Giving ADT Progressing To CRPC
35. Clinical Significance Of Gleason Score,T Stage And PSAD In Predicting PSA Progression After Radical Prostatectomy For Intermediate-risk Prostate Cancer
36. Correlation Between Testosterone Concentration Control And Disease Progression In Patients With Metastatic Hormone-sensitive Prostate Cancer(mHSPC)
37. Correlation Between Prostate-specific Antigen Dynamics And Progression Time Of Castration-Resistant Prostate Cancer After Androgen Deprivation
38. Comparison Of Efficacy Between Cytoreductive Radical Prostatectomy Combined With Androgen Deprivation Therapy Versus Androgen Deprivation Therapy Alone For Oligometastatic Prostate Cancer: A Meta-analysis
39. Efficacy Of Chemotherapy Combined With Hormonal Therapy For Metastatic Castration-sensitive Prostate Cancer And Prognosis Of The Patients
40. Analysis Of Related Factors Of Castration-resistant Prostate Cancer
  <<First  <Prev  Next>  Last>>  Jump to